FedSmith reports that the TrumpRx initiative could drive changes to FEHB prescription drug pricing and related rules. If implemented broadly, it may affect FEHB plan premiums, covered benefits, and federal oversight of pharmacy benefit practices.
Read full story at FedSmith →Related Topics
fehbprescription-drug-pricingopmhealth-insurance-premiumspharmacy-benefits